Various cells of the immune system and intestine differ in their capacity to reduce hexavalent chromium by Shrivastava, Richa et al.
Various cells of the immune system and intestine di¡er in their
capacity to reduce hexavalent chromium
Richa Shrivastava, R.K. Upreti, U.C. Chaturvedi 
Biomembrane Division, Industrial Toxicology Research Centre, Mahatma Gandhi Marg, Lucknow 226001, India
Received 4 January 2003; received in revised form 13 March 2003; accepted 21 March 2003
First published online 10 April 2003
Abstract
The cells of the immune system form a strong line of defence against foreign substances. The present study was undertaken to
investigate the capacity of different cells of Wistar rats to reduce potentially carcinogenic hexavalent chromium (Cr-VI) into less toxic
trivalent chromium in vitro. 5U106 cells were incubated with 10 or 25 Wg ml31 of Cr (VI) in the form of K2Cr2O7 at 37‡C in the presence
of 5% CO2 in air. At various time periods the remaining amount of Cr (VI) was measured and the percentage of Cr (VI) reduced was
calculated. Among the single cell suspensions from the splenic cells a peak reduction of 55% was observed with the total spleen cells, 40%
with the B-lymphocyte-enriched subpopulation, 10% with T-lymphocytes and 24% with the macrophages. The reduction by splenic and
peritoneal macrophages was similar. Total thymocytes reduced 54% of the Cr (VI). Since the most common route of entry of chromium is
through drinking water and food, intestinal cells were also investigated. Among the intestinal cells the maximum reduction of 100% (of 10
Wg ml31) was observed with the upper villus cells and 72% with the middle villus cells while reduction was the least (4%) with the crypt
cells. The reduction in the intestinal loop in situ was 100%. The time taken by each cell type for the peak reduction to Cr (VI) was
markedly different. The findings thus show that the capacity of different cells in the body differs vastly in their capacity and time taken to
reduce hexavalent chromium. The most efficient handling of Cr (VI) by the intestine, due to the presence of a variety of cells and bacteria,
protects the body from its adverse effects.
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1. Introduction
Environmental contamination by chromium (Cr) is
common in industrialized areas. Chromium pollution as
a consequence of e¥uent discharge from tanneries and
other industries, which include metal plating, manufactur-
ing industries and ferrochrome production, poses a serious
problem for environmental quality. In aqueous environ-
ments chromium has two oxidation states: hexavalent
chromium (Cr-VI) and trivalent chromium (Cr-III). Cr
(VI) compounds are generally soluble over a wide pH
range and have been shown to exert toxic and carcinogen-
ic e¡ects in humans and experimental animals [1^5]. In
addition, Cr (VI) compounds also induce DNA damage
such as DNA single-strand breaks and DNA^protein
crosslinks in vivo and in cultured cells [6]. Cr (VI) com-
pounds are much more toxic than those of Cr (III) due to
their higher solubility in water, rapid permeability through
biological membranes and subsequent interaction with in-
tracellular proteins and nucleic acids. Non-biodegradabil-
ity of heavy metals is responsible for their persistence in
the environment and their subsequent bioaccumulation in
the food chain. The presence of chromate in the environ-
ment inhibits most microorganisms, but also promotes the
selection of resistant bacteria [7].
Chromium enters the body through the lungs, gastro-
intestinal tract, and to a lower extent through skin [8].
Inhalation is the most important route for occupational
exposure, whereas non-occupational exposure occurs via
ingestion of chromium-containing food and water [9,10].
Regardless of the route of exposure Cr (III) is poorly
absorbed whereas Cr (VI) is more readily absorbed [8],
although less well by the oral route and thus is not very
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toxic when introduced by this route [11]. In contrast, chro-
mium is very toxic by dermal and inhalation routes and
causes lung cancer, nasal irritation, nasal ulcer, hypersen-
sitivity reactions and contact dermatitis. Most of the chro-
mium absorbed by inhalation exposure, in comparison to
oral administration, is distributed in the lungs, liver, kid-
neys, red blood cells, plasma, spleen and bone marrow [9].
All the ingested Cr (VI) is reduced to Cr (III) before enter-
ing the blood stream [12]. Cr (VI) enters the cells through
membrane anionic transporters while Cr (III) does not.
Intracellular Cr (VI) is metabolically reduced to the ulti-
mate Cr (III). It is therefore in the interest of the body to
reduce the toxic Cr (VI) to the less toxic form, Cr (III).
The cells of the immune system form a strong line of
defence against foreign substances and the most common
route of entry of chromium is through drinking water and
food. The present study was, therefore, undertaken to in-
vestigate the capacity of di¡erent cells of the immune sys-
tem and intestine of Wistar rats to reduce Cr (VI).
2. Materials and methods
2.1. Animals
The study was carried out on Wistar rats weighing 200^
250 g and maintained in the Animal House of the Insti-
tute.
2.2. Preparation of spleen cells
The rats were sacri¢ced by cervical dislocation and the
spleens were removed aseptically. The spleen cells were
teased out in cold heparinized Eagle’s minimum essential
medium containing non-essential amino acids (MEM) and
a single cell suspension was obtained. The cells were
washed and viable cell count done by the trypan blue
dye exclusion test [13].
2.3. Preparation of splenic macrophages
Spleen cell suspension was incubated at 37‡C for 2 h in
an atmosphere of 5% CO2 and the glass non-adherent cells
were decanted gently. The glass-adherent cells were
washed thrice with MEM and scraped o¡ with a police-
man rod and resuspended as a single cell suspension. More
than 95% of the cells were phagocytic [14].
2.4. Separation of T- and B-lymphocytes
T- and B-lymphocytes were separated with glass wool
and nylon wool columns by the technique of Julius et al.
[15] and Trigio and Cudkowicz [16]. The e¥uent (T-lym-
phocytes) and the eluted cells (B-lymphocytes) were cen-
trifuged separately and resuspended in cold MEM and the
purity was tested as described elsewhere [17].
2.5. Preparation of peritoneal macrophages
The peritoneal cavity of rats was lavaged with 10 ml
of MEM. The aspirated cells were layered in a glass
Petri dish and incubated at 37‡C in the presence of 5%
CO2 for 2 h. The glass non-adherent cells were removed
by washing three times. The glass-adherent cells were
scrapped o¡ with a policeman rod. Cells were resuspended
in MEM and a single cell suspension was prepared [14].
2.6. Preparation of thymocytes
A single cell suspension of thymocytes was prepared in
MEM with 10% fetal calf serum as described by Debetto
et al. [18]. The viable cell count was done by the trypan
blue dye exclusion test.
2.7. Isolation of intestinal epithelial cells of various
di¡erentiation stages from crypt to villus
Rats were fasted overnight and sacri¢ced by cervical
dislocation and decapitation. Small intestine was removed
and £ushed gently with normal saline containing 1.0 mM
dithiothreitol. Intestinal epithelial cells were prepared
along the crypt to villus axis on a gradient of di¡erentia-
tion according to Weiser [19]. Brie£y, the cecal end of the
intestine was ligated and ¢lled with solution ‘A’ containing
1.5 mM KCl, 96 mM NaCl, 27 mM sodium citrate, 8 mM
KH2PO4 (pH 7.3) after clamping the other end with artery
forceps. The intestine was then immersed in solution ‘A’
and incubated at 37‡C for 15 min in a constant water
bath. After incubation the intestine was emptied and £uid
discarded. The intestine was now ¢lled with solution ‘B’
containing 1.5 mM EDTA and 5 mM dithiothreitol in
phosphate-bu¡ered saline (pH 7.2) and immersed in solu-
tion ‘B’ for incubation. After 4 min incubation, the con-
tents were emptied into a plastic centrifuge tube to recover
the ¢rst epithelial cell population. The intestine was ¢lled
with solution ‘B’ for di¡erent time intervals and the pro-
cess was repeated for several times to collect cell popula-
tions of di¡erentiation stages. Cell populations were cen-
trifuged at 900Ug for 5 min and washed twice with 4 mM
EDTA solution containing 15 mM L-mercaptoethanol (pH
7.4) to remove phosphate bu¡er. For this experiment, ep-
ithelial cells in their sequence of dissociation from the in-
testine were pooled into three fractions on the basis of
their protein content and alkaline phosphatase activity as
described by Panini et al. [20]. These fractions were des-
ignated as upper villi, middle villi and crypt respectively.
From each fraction 5U106 cells ml31 were used in the
tests.
2.8. Experiments on intestinal cells in situ
Laparotomy on each rat was performed by midline in-
cision under light ether anesthesia. The intestine was
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washed with normal saline, using a syringe and a blunt
needle, through two small cuts. One was made slightly
distal to the duodeno^jejunal junction and another at
the distal end of the ileum. After washing, the opening
was ligated and 10-cm-length loops were prepared from
the upper end of the intestine using sterile threads [21].
Test solution was administered into the loops through a
proximal opening, which was then immediately ligated.
Control loops contained normal physiologic saline solu-
tion. The whole intestine was kept in situ and the abdo-
men stitched immediately. Proper breathing and anesthe-
sia of the animal was maintained throughout the
experiment. Loops were removed after 30 min incubation,
gently blotted on ¢lter paper, and the contents were
drained into graduated tubes. The luminal £uid was
made up to the desired volume and centrifuged at
500Ug for 5 min to remove any intestinal debris.
2.9. Estimation of Cr (VI) reduction by the cells
Potassium dichromate (hexavalent chromium; Cr (VI))
was of analytical grade (M/S Qualigens, Lucknow, India).
Chromium solution was prepared in MEM containing 10
or 25 Wg ml31 of chromium. 5U106 cells were suspended
in 1 ml chromium solution and incubated at 37‡C. At
di¡erent time periods an aliquot was taken, the cells
were removed by spinning and the reduction of Cr (VI)
was assayed in the cell-free supernatant spectrophotomet-
rically at 540 nm using diphenylcarbazide reagent [22]. The
experiments were setup in triplicate and were repeated
thrice. The mean data TS.D. have been presented as per-
centage reduction of Cr (VI).
3. Results
3.1. Reduction of Cr (VI) by splenic lymphocytes
The data summarized in Fig. 1 show that total spleen
cells suspended in 10 Wg ml31 of Cr (VI) reduced 55T 10%
of it in 1 h and the same level was maintained throughout
the period of observation. The reduction by the enriched
subpopulation of B-lymphocytes was 18T 5% at 1 h and
gradually increased reaching a peak of 40T 8% reduction
at 6 h of incubation. The least e¡ective cells were the
enriched subpopulation of T-lymphocytes that reduced
10T 2% of the Cr (VI) at 8 h.
3.2. Reduction of Cr (VI) by macrophages
Macrophages obtained from rat spleen and peritoneal
cavity were used. The ¢ndings presented in Fig. 2 show
that with 10 Wg Cr (VI) the peak reduction of 22T 5% was
   
Fig. 1. Reduction of Cr (VI) by rat spleen cells or its enriched subpopu-
lations. A single cell suspension of normal rat spleen was prepared and
enriched subpopulations of total lymphocytes were obtained by deplet-
ing macrophages with a glass wool column and the T- and B-lympho-
cyte-enriched subpopulations were prepared with a nylon wool column.
5U106 cells ml31 were suspended in MEM containing 10 Wg Cr (VI).
At di¡erent time periods a group of sets were removed and Cr (VI)
measured. The ¢ndings have been presented as mean valueT S.D. (bars)
from repeated experiments as percentage reduction.
0
5
1 0
1 5
2 0
2 5
3 0
3 5
1 2 4 6 8 1 2 2 4
TIME PERIOD (HOURS)
Peritonial Macrophages (10ug)
Splenic Macrophages (10ug)
Peritonial Macrophages (25ug)
Splenic Macrophages (25ug)
%
 R
E
D
U
C
T
IO
N
 O
F
 C
r(
V
I)
Fig. 2. Reduction of Cr (VI) by macrophage-enriched cells obtained
from rat peritoneal lavage cell and the spleen. The peritoneal lavage or
the single cell suspension of spleen was layered in a glass Petri dish and
incubated at 37‡C for 2 h in the presence of 5% CO2. Then the adher-
ent cells were scrapped o¡, counted and tested (5U106 cells ml31) as de-
scribed in Fig. 1 using 10 and 25 Wg of Cr (VI).
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attained by splenic macrophages at 12 h while that by the
peritoneal macrophages was similar, the peak being
24T 7% at 12 h. This experiment was repeated using a
higher dose of 25 Wg chromium. A lower percentage of
reduction (nearly half of the 10 Wg) was observed with
the higher Cr (VI) concentration (Fig. 2).
3.3. Reduction of Cr (VI) by thymocytes
The total cell population obtained from the rat thymus
was suspended in 10 and 25 Wg concentration of chromium
and incubated for di¡erent time periods. The data pre-
sented in Fig. 3 show that thymocyte gradually reduced
Cr (VI) reaching peak reduction at 24 h. The reduction
was 54T 15% with a Cr (VI) concentration of 10 Wg and
28T 8% in 25 Wg concentration (Fig. 3).
3.4. Reduction of Cr (VI) by intestinal cells in vitro
Cells obtained from upper and middle villus and the
crypts of the intestine were studied for their capacity to
reduce Cr (VI). The ¢ndings summarized in Fig. 4 show
that the reduction was 85T 12% to 100% by the cells from
the upper villus using the two concentrations of Cr (VI).
The reduction was minimal with the cells from the crypts
while that by the cells from the middle villus was 55T 12%
to 72T 18% (Fig. 4).
3.5. Reduction of Cr (VI) by intestinal cells in situ
The intestinal loops were blotted on ¢lter paper, and the
contents were drained into graduated tubes. The luminal
£uid was made up to the desired volume and centrifuged
to remove any intestinal debris. The Data summarized in
Fig. 5 show that the reduction of Cr (VI) was 100%,
90T 7% and 90T 10% with 10, 50 and 100 Wg Cr (VI)
respectively.
4. Discussion
The main ¢nding of the present study is that various
cells of the body di¡er in their capacity to reduce Cr (VI).
Among the isolated rat cells tested, peak reduction of
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Fig. 4. Reduction of Cr (VI) by rat intestinal cells. Rat intestines were
removed and di¡erent types of cells were removed and a single cell sus-
pension was prepared and tested (5U106 cells ml31) as described in Sec-
tion 2.
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Fig. 5. Reduction of Cr (VI) by rat intestinal loop in situ. Rat intestines
were exteriorized, lumen washed and di¡erent doses of Cr (VI) injected
in lumen, and Cr (VI) reduction tested as described in Section 2.
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Fig. 3. Reduction of Cr (VI) by rat thymocytes. Total thymus was re-
moved from the rat and a single cell suspension was prepared and
tested (5U106 cells ml31) as described in Fig. 1.
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100% was seen by upper villus cells of intestine while the
least (4%) was seen with the crypt cells of the intestine, the
other cells were in between. Chromium is of signi¢cant
importance in altering the immune response by immuno-
stimulatory or immunosuppressive mode as shown by its
e¡ects on T- and B-lymphocytes, macrophages, cytokine
production and the immune response that may induce
hypersensitivity reactions [23]. Cells of the immune system
form the ¢rst line of defense in the body. These cells dif-
fered vastly in their capacity and the time taken to reduce
Cr (VI). The most e¡ective were the total spleen cells
(55 T 10%) and thymocytes (54T 15%), followed by the
B-lymphocyte-enriched subpopulation of spleen (40T 8%)
and least e¡ective were T-lymphocytes (10T 2%) while
macrophages reduced 24T 7% of the Cr (VI). DeFlora et
al. [11] have reported similar ¢ndings with lung alveolar
macrophages.
Cr (VI) enters the cells through membrane anionic
transporters but Cr (III) does not. While detoxifying Cr
(VI), the cells themselves may get damaged. Chromium-
induced damage to DNA both in the gastric mucosa cells
and lymphocytes has been studied by comet assay and the
e¡ects were found to be similar in both [24,25]. Some of
the important factors in determining the biological out-
come of chromium exposure include the bioavailability,
chemical speciation and solubility of chromium com-
pounds, intracellular reduction, and interaction of chromi-
um with DNA. Intracellular Cr (VI) is metabolically re-
duced to the ultimate Cr (III). Cr (VI) does not react with
macromolecules such as DNA, RNA, proteins and lipids;
however, both Cr (III) and the reductional intermediate Cr
(V) are capable of co-ordinate, covalent interactions with
macromolecules. A series of in vitro and in vivo studies
have demonstrated that Cr (VI) induces oxidative stress
through enhanced production of reactive oxygen species
leading to genomic DNA damage and oxidative deterio-
ration of lipids and proteins. A cascade of cellular events
occurs following Cr (VI)-induced oxidative stress including
enhanced production of superoxide anion and hydroxyl
radicals, increased lipid peroxidation and genomic DNA
fragmentation, modulation of intracellular oxidized states,
activation of protein kinase C, apoptotic cell death and
altered gene expression [23,26,27].
Chromium enters the body through the lungs, gastro-
intestinal tract, and to a lower extent through skin [8]. The
most important route for non-occupational exposure is via
ingestion of chromium-containing food and water. Re-
gardless of the route of exposure Cr (III) is poorly ab-
sorbed whereas Cr (VI) is more readily absorbed [9,
10,12]. Further, Cr (VI) is not very toxic when intro-
duced by the oral route and it was thought to be due to
poorer absorption by this route. But our ¢ndings show
that the reason was e⁄cient detoxi¢cation of Cr (VI) by
reduction in the intestines. The most e⁄cient reduction
(100%) of Cr (VI) was observed by the whole intestinal
loop. A number of components in the intestines may be
responsible for such e⁄cient handling of Cr (VI). When
introduced by the oral route, Cr (VI) is e⁄ciently reduced
by upper villus cells (100%), the middle villus cells
(72 T 18%) and the crypt cells (4%) of the intestine as
shown in the present study. The intestinal bacterial £ora,
including Escherichia coli, Lactobacillus sp., Pseudomonas
sp. and Staphylococcus sp. have been found to be e⁄cient
reducers of Cr (VI) (personal unpublished data). The ¢nd-
ings of the present study also suggest that whatever Cr
(VI) crosses over the intestinal wall can be e⁄ciently re-
duced by the lymphocytes and macrophages present in the
lymphoid follicles of the intestinal wall and also in the
lymph nodes of the omentum. Our ¢ndings ¢nd support
in the study of DeFlora et al. [11] who have shown that
saliva and gastric juice and sequestration by intestinal bac-
teria, blood, liver are e⁄cient Cr (VI) reducers. This is
further supported by a number of studies where chronic
oral exposure to Cr (VI) exhibited no adverse e¡ects [28^
30]. Further, Cr (VI) is reduced to variable degrees in
di¡erent tissues and organs, such as peripheral lung paren-
chyma, bronchial tree, kidney, testis, stomach, spleen,
plasma and adrenals etc. [31]. The present study is unique
in the sense that isolated cell suspensions have been tested.
The reduction of Cr (VI) to Cr (III) results in the forma-
tion of reactive intermediates that contribute to the cyto-
toxicity, genotoxicity, and carcinogenicity of Cr (VI)-con-
taining compounds. These mechanisms of reduction of Cr
(VI) explain the lack of genotoxicity, carcinogenicity, and
induction of other long-term health e¡ects of Cr (VI) by
the oral route.
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